Multimodality imaging provides essential anatomical and tissue characterization to guide the diagnosis and management of benign primary cardiac tumors.
Multimodality imaging provides essential complementary diagnostic and prognostic information for the management of benign primary cardiac tumors.
Primary cardiac tumors (PCTs) are rare, with benign PCTs being relatively common in approximately 75% of all PCTs. Benign PCTs are usually asymptomatic, and they are found incidentally by imaging. Even if patients present with symptoms, they are usually nonspecific. Before the application of imaging modalities to the heart, our understanding of these tumors is limited to case reports and autopsy studies. The advent and improvement of various imaging technologies have enabled the non-invasive evaluation of benign PCTs. Although echocardiography is the most commonly used imaging examination, it is not the best method to describe the histological characteristics of tumors. At present, cardiac magnetic resonance (CMR) and cardiac computed tomography (CCT) are often used to assess benign PCTs providing detailed information on anatomical and tissue features. In fact, each imaging modality has its own advantages and disadvantages, multimodality imaging uses two or more imaging types to provide valuable complementary information. With the widespread use of multimodality imaging, these techniques play an indispensable role in the management of patients with benign PCTs by providing useful diagnostic and prognostic information to guide treatment. This article reviews the multimodality imaging characterizations of common benign PCTs.
Lin et al. (Thu,) conducted a review in Benign Primary Cardiac Tumors. Multimodality imaging was evaluated. Multimodality imaging provides essential anatomical and tissue characterization to guide the diagnosis and management of benign primary cardiac tumors.